LISA LEWIS: Open Payments
NPI 1518118694 · WEST HEMPSTEAD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 55 payments from 11 companies in 2025. Trend: 2023 $806 · 2024 $1,326 · 2025 $1,325
Food & beverage: $1,325
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 7 | $276 |
| Ardelyx, Inc. | 11 | $255 |
| Novartis Pharmaceuticals Corporation | 7 | $166 |
| Vifor Pharma, Inc. | 9 | $164 |
| Calliditas Therapeutics US Inc. | 5 | $116 |
| Otsuka America Pharmaceutical, Inc. | 6 | $115 |
| AKEBIA THERAPEUTICS INC | 4 | $101 |
| Aurinia Pharma U.S., Inc. | 2 | $45 |
| OPKO Pharmaceuticals, LLC | 2 | $43 |
| Fresenius USA Manufacturing, Inc. | 1 | $23 |
Products named: IBSRELA, Veltassa, Filspari, TARPEYO, Vanrafia, Vafseo, JYNARQUE, LUPKYNIS.
Industry payments across NY — which companies pay providers there.
